South Korea Automated Microbiology Market Size, Share, and COVID-19 Impact Analysis, By Product (Instruments, Reagent & Kits, and Software), By Automation Type (Fully Automated and Semi Automated), By Application (Clinical Diagnostics and Biopharmaceutical Production ), By End-use (Hospital & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, and Other End-use), and South Korea Automated Microbiology Market Insights, Industry Trend, Forecasts to 2035

South Korea Automated Microbiology Market Insights Forecasts to 2035

• The South Korea Automated Microbiology Market Size Was Estimated at USD 138.3 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 12.80% from 2025 to 2035
• The South Korea Automated Microbiology Market Size is Expected to Reach USD 520.1 Million by 2035

According to a research report published by Spherical Insights and Consulting, The South Korea Automated Microbiology Market Size is anticipated to reach USD 520.1 Million by 2035, growing at a CAGR of 12.80% from 2025 to 2035. The market for automated microbiology is the rising incidence of infectious diseases. Rapid and precise microbial identification and susceptibility testing are becoming more and more necessary as hospital-acquired infections (HAIs), foodborne diseases, and antimicrobial resistance (AMR) increase.

Market Overview

The automated microbiology market involves the use of advanced technologies and automated systems to detect, identify, and analyse microorganisms in clinical, pharmaceutical, food, and environmental samples. This automation improves accuracy, speeds up diagnosis, reduces manual labor, and enhances lab efficiency. Key benefits include reduced human error, faster turnaround times, and higher throughput. The market presents opportunities for expanding diagnostics, personalized medicine, and increasing demand for rapid testing solutions. Growth is derived from rising healthcare needs and advancements in AI and robotics. Government initiatives like funding for healthcare innovation, pandemic preparedness, and improved disease surveillance systems support market expansion, particularly in developing nations aiming to strengthen public health infrastructure and laboratory capabilities.

Report Coverage

This research report categorizes the market for South Korea automated microbiology market based on various segments and regions forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the South Korea automated microbiology market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment South Korea automated microbiology market.

Driving Factors        

The automated microbiology market is driven by the growing demand for faster and more accurate diagnostic solutions, increasing prevalence of infectious diseases, and the rising need to reduce human error in laboratories. Technological advancements in robotics, AI, and laboratory instruments also fuel market growth. Additionally, the surge in hospital-acquired infections and the emphasis on improving patient outcomes push healthcare facilities toward automation. Government support and investments in healthcare infrastructure further accelerate the adoption of automated microbiology systems.

Restraining Factors

A primary restraint is the high initial investment required for automated systems, which can be prohibitive for smaller laboratories and healthcare facilities. Additionally, the lack of skilled personnel to operate and maintain these advanced technologies poses a significant barrier. Integration issues with existing infrastructure and resistance to change from traditional manual workflows further slow adoption rates. Regulatory hurdles and concerns over data security also contribute to the cautious approach towards automation in microbiology laboratories.

Market Segmentation

The South Korea Automated Microbiology Market share is classified into product, automation type, application, and end-use.

• The instruments segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea automated microbiology market is segmented by product into instruments, reagent & kits, and software. Among these, the instruments segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is driven by the growing burden of infectious illnesses, the growing demand for high-throughput microbiological testing, and technological developments in automation. To increase precision, lower manual error rates, and speed up turnaround times, labs are implementing automated tools such blood culture analysers, microbial identification systems, and antibiotic susceptibility testing (AST) devices.

• The fully automated segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea automated microbiology market is segmented by automation type into fully automated and semi-automated. Among these, the fully automated segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period. The growing demand for high-throughput, precise, and quick microbiological diagnostics in clinical, pharmaceutical, and food safety labs is driving the expansion of the completely automated microbiology sector. In order to manage the growing burden of infectious diseases and antibiotic resistance, fully automated systems limit human intervention, lowering errors and increasing efficiency.

• The clinical diagnostics segment dominated share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea automated microbiology market is segmented by application into clinical diagnostics and biopharmaceutical production. Among these, the clinical diagnostics segment dominated share in 2024 and is expected to grow at a significant CAGR during the forecast period. The decreasing manual labor, limiting human error, and speeding up turnaround times for antibiotic susceptibility testing (AST) and microbiological identification, automation improves laboratory efficiency. Adoption in clinical laboratories is being further accelerated by technological developments including integrated automation platforms, molecular diagnostics, and AI-driven data analysis.

• The clinical diagnostics segment held a majority share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea automated microbiology market is segmented by end-use into hospital & diagnostic laboratories, pharmaceutical & biotechnology companies, academic & research institutes, and other end-use. Among these, the clinical diagnostics segment held a majority share in 2024 and is expected to grow at a significant CAGR during the forecast period. The demand for quicker, more precise microbiological diagnostics, growing worries about antibiotic resistance, and the increase in infectious illness prevalence are the main factors driving the market.  

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the South Korea automated microbiology market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the companies' current news and developments, including product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Seegene Inc.
• Kogene Biotech
• Mega Medical Co., Ltd.
• LISCure Biosciences Inc.
• OPTOLANE Technologies Inc.
• Doosan Robotics
• GC Biopharma
• Samsung Biologics
• Boditech Med
• Lotte Biologics
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at South Korea, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the South Korea automated microbiology market based on the below-mentioned segments:

South Korea Automated Microbiology Market, By Product

• Instruments
• Reagent & Kits
• Software

South Korea Automated Microbiology Market, By Automation Type

• Fully Automated
• Semi-Automated

South Korea Automated Microbiology Market, By Application

• Clinical Diagnostics
• Biopharmaceutical Production

South Korea Automated Microbiology Market, By End-use

• Hospital & Diagnostic Laboratories
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Other End-use